Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
Condition(s):HIV InfectionsLast Updated:March 28, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:March 28, 2024Recruiting
Condition(s):HIV-1 InfectionLast Updated:January 16, 2024Recruiting
Condition(s):HIV InfectionsLast Updated:August 3, 2023Recruiting
Condition(s):HIV InfectionsLast Updated:February 13, 2024Recruiting
Condition(s):HIV-1-infectionLast Updated:October 23, 2023Recruiting
Condition(s):Hiv; HIV Infections; HIV-1-infection; Paediatric Human Immunodeficiency Virus InfectionLast Updated:February 9, 2024Recruiting
Condition(s):HIVLast Updated:October 30, 2023Not yet recruiting
Condition(s):HIV InfectionsLast Updated:July 20, 2023Recruiting
Condition(s):Human Immunodeficiency Virus; Opioid Use DisorderLast Updated:August 14, 2023Recruiting
Condition(s):HIV-1-infection; Pregnancy; PostpartumLast Updated:March 28, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.